Pasireotide

Products Pasireotide is commercially available as an injectable (Signifor, Signifor LAR). It was approved in the EU and many countries in 2012. Structure and properties Pasireotide (C59H67N9O9, Mr = 1046.2 g/mol) is present in the drug as pasireotide diaspartate or as pasireotide pamoate. It is a cyclohexapeptide and an analog of the hormone somatostatin. Somatostatin … Pasireotide

Octreotide

Products Octreotide is commercially available as an injectable (Sandostatin, Sandostatin LAR, generics). It has been approved in many countries since 1988. Structure and properties Octreotide is a synthetic octapeptide derivative of the hormone somatostatin. It is present in the drug as octreotide acetate and has the following structure: D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol, xCH3COOH (x = 1.4 to 2.5). … Octreotide

What is Acromegaly?

Acromegaly is a rare metabolic disorder that causes excessive growth of limbs. Acromegaly means something like “enlargement of the outermost parts of the body.” Affected individuals have very large ears, nose, hands and feet. The cause is a brain tumor that leads to overproduction of a growth hormone. Acromegaly can be inherited through gene mutations. … What is Acromegaly?

Pegvisomant

Products Pegvisomant is commercially available as a powder and solvent for the preparation of a solution for injection (Somavert). It has been approved in many countries since 2005. Structure and properties Pegvisomant is a derivative of human growth hormone produced by biotechnological methods. It consists of 191 amino acids and is pegylated at several sites. … Pegvisomant

Acromegaly: Too Much Growth Hormone

Definition Acromegaly refers to a pathological change in growth due to chronic somatotropin excess. The condition occurs primarily in individuals aged 40-50 years. If acromegaly is not adequately treated, life expectancy is shortened by approximately 10 years due to secondary diseases. Symptoms The symptoms of acromegaly initially remain inconspicuous. The symptoms are nonspecific and develop … Acromegaly: Too Much Growth Hormone

Bromocriptine

Products Bromocriptine is commercially available in tablet form (Parlodel). It was developed at Sandoz in the 1960s and has been approved in many countries since 1975. Generic versions are now available in many countries. Structure and properties Bromocriptine (C32H40BrN5O5, Mr = 654.6 g/mol) is a brominated derivative of the natural ergot alkaloid ergocryptine. It is … Bromocriptine

Bromocriptine: Effects, Uses & Risks

Bromocriptine is an active substance that belongs to the group of ergot alkaloids. The active ingredient is used primarily if there is a disease that is due to too high a level of prolactin in the blood. What is bromocriptine? Because of its special properties, bromocriptine is used to treat health problems and diseases that … Bromocriptine: Effects, Uses & Risks

Carney Complex: Causes, Symptoms & Treatment

Patients with Carney complex are conductively symptomatic of hormonal imbalances and myxomas. The disease is a mutation-related inherited disorder. Treatment is supportive symptomatic and primarily involves surgical removal or monitoring of myxomas and other tumors. What is a Carney complex? So-called myxomas are benign tumors composed of unformed connective tissue and mucinous gelatinous substance. The … Carney Complex: Causes, Symptoms & Treatment

Hyperostosis: Causes, Symptoms & Treatment

In hyperostosis, bone tissue increases. The culprit is usually increased activity of osteoblasts. Drug treatment options are now available for treatment in addition to curettage. What is hyperostosis? In hyperplasia, a tissue or organ enlarges by increasing its cell count. This increase in cell number is usually a response to functionally increased stress or hormonal … Hyperostosis: Causes, Symptoms & Treatment